A Phase 3 Study of the Hepcidin Mimetic Rusfertide (PTG-300) in Patients with Polycythemia Vera
To evaluate the safety and efficacy of rusfertide in subjects with polycythemia vera in maintaining hematocrit control.
University of Colorado Hospital
Brandon Mcmahon, MD
Protocol Number: 22-0305
More information available at ClinicalTrials.gov: NCT05210790
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers